RE:RE:Looks good to me. It may seem that way to some, but there's no ilmenite revenue in the report, which is expected to reach 150 kt annually after ramp-up per the company's February powerpoint presentation. There's also the prospect of PGMs. There's a potential catalyst with Stryten, and VRFB installations are beginning to ramp worldwide, which is expected to significantly increase V demand over time. V prices are volatile, so this stock isn't for everyone. Need stomach here, especially with 67% institutional ownership and low volume.